Alex is a commercially driven public company board director with over 25 years’ experience in senior operational roles. Alex brings extensive international experience driving transformational growth and shareholder value across high-tech manufacturing, Photonics and regulated MedTech sectors. He was previously Group Managing Director of SDI Group plc and before that Chief Operating Officer at Foster & Freeman Ltd, Gooch & Housego plc, and Optos plc. He has a proven track record in delivering profitable revenue growth and operational excellence, developing new products, and commercialising complex clinical technologies with an entrepreneurial, hands-on approach to scaling innovative smaller enterprises and navigating highly regulated global markets.

David has over 25 years’ experience within the medical industry, 20 of which have been in senior management positions. David joined Auto Suture (Medtronic ) in 1991 before being appointed Sales Director then General Manager of SkyMed Ltd. Following the acquisition of SkyMed by Gyrus David was appointed Managing Director of the Direct Operations in U.K. Benelux and Germany, before assuming the position of Vice President of Sales and Marketing for Europe. As part of the Gyrus Senior Management team David was involved in the many acquisitions made by the Company and led the European integration of the enlarged business. During his career David has been responsible for the introduction of a number of key technologies across a broad spectrum of specialities. In 2006 David was Co-Founder of Elemental Healthcare Ltd.

Roy is an experienced executive with over 35 years of global experience in a variety of industries including medtech, diagnostics and technology sectors. He is currently Chairman of Inspiration Healthcare Group plc, a leading neonatal respiratory company, and Foster & Freeman Ltd (the trading name of the Galton group of companies), a leading forensic imaging manufacturer. He is also a Non-Executive Director of Futura Medical plc, a UK pharmaceutical company focussed on the sexual health market and a Senior Advisor to Moore Walker Partners, a Healthcare & Technology Advisory Services company. Roy was previously Chairman of LunglifeAI plc, Medica Group plc until its sale to IK Partners in 2023 and Chairman of Edinburgh Molecular Imaging Ltd and RAIR Health Ltd.

Before these Non-Executive roles Roy served as the Chief Executive Officer of Optos plc, a leading ophthalmology medical device business, from 2008 until June 2016 when he stepped down following the company’s acquisition by Nikon Corporation. Before joining Optos, he served from 2007 as Chief Executive Officer of Gyrus Group plc, a leading medical device company, prior to its acquisition by the Olympus Corporation of Japan in 2008, having previously served as Chief Operating Officer of Gyrus from 2003 and a Non-Executive Director since the company’s flotation in 1997.

Prior to this, Roy spent almost ten years with Arthur D Little, the global management consulting company, where he was vice president and global head of its operations management business. His early career included experience in the electronics, oil, and automotive sectors. Roy holds a mechanical engineering degree from the University of Southampton and an MBA from the London Business School.

Roy will become Chair of the Nomination Committee and be a member of the Renumeration and Audit Committees, effective immediately.

Andrew brings more than 30 years’ experience in both Executive and Non-Executive roles in the financial sector. Andrew is currently Non-Executive Director and Audit Committee Chair at Octopus AIM VCT plc and Non-Executive Director and Audit Committee Chair at Cake Box Holdings plc. Andrew was previously Non-Executive Director and chair of Remuneration and Audit at LungLifeAI plc. He has been on CEN Group Holdings’ Advisory Panel since 2021. Previously, he was CFO at Gooch & Housego PLC (2009–2019) and Finance Director at Riverford Organic Farmers (2019–2023).

Andrew will become Chair of the Audit and Remuneration Committees and a member of the Nominations Committee, effective immediately.

Duncan has over 35 years of investment experience. Having worked in investment banking for 10 years (1984-1994), latterly with Bear Stearns as managing director in charge of the company’s non-US equity business, Mr Soukup set up his own investment management business in 1994. Acquisitor plc, a company of which Mr Soukup was a director, was admitted to trading on AIM in January 2000. In 2002, 90 per cent. of the assets of Acquisitor Plc were moved to Acquisitor Holdings Ltd (Bermuda) and Acquisitor Plc was left as an investing company which then acquired Tinopolis Plc, a leading UK independent TV production company. In 2006, Acquisitor Holdings Limited (Bermuda) merged with New York Holdings Ltd. and Baltimore Plc. Shortly thereafter, the combined group was acquired by Oryx International Limited, a Guernsey incorporated investment company. Mr Soukup is currently a Director of a number of UK listed companies including Thalassa Holdings Ltd., Alina Holdings Plc., and Anemoi International Ltd.

Duncan will be a member of the Nominations and Audit Committees, with immediate effect.

David is an experienced board director with over 28 years’ experience in senior finance roles. He is a chartered accountant and member of the Institute of Chartered Accountants of England and Wales, qualifying with Stoy Hayward (now BDO LLP). From 1998 to 2009 David was an audit partner in their London office before becoming an audit partner with Crowe Clark Whitehill (now Crowe U.K. LLP) from 2010 to 2012. Since then, David has held senior finance roles with Strategic Minerals Plc, Hakkasan Limited and CT Group International Ltd. He currently acts as the CFO and board member of LungLife AI, Inc, and as the non-board CFO and Company Secretary of Verici Dx Plc.

Stephen Seed, Chief Compliance Officer, graduated in Geology from Sheffield in the 1980’s and began his career in the mining industry as a Shift Chemist, moving into the chemical industry and becoming a Quality Manager in 1989. He joined H B Fuller Plc, an international adhesive manufacturer, as UK Quality Manager, where he studied for a Diploma in Quality Assurance and became a Chartered Quality Professional. In 2006 Steve moved into the medical device industry at Surgical Innovations as Quality Manager, where he gained a National Diploma in Health and Safety and became a Chartered Health and Safety Practitioner. Steve moved on to gain wider experience in the medical device industry, first as QA/RA Manager in a medical lighting company, moving to a medical textile implant company where he became Compliance Director in 2014, worked closely with the R&D team to introduce a range of new devices, gained a master’s degree in Medical Technology and Regulatory Affairs, and became a member of The Organisation for Professionals in Regulatory Affairs. In 2019 Steve returned to Surgical Innovations to head up the Compliance team and is responsible for Quality, Regulatory Affairs, Research and Development, Health and Safety and Environment.

Richard has over 23 years of experience in manufacturing across the Aerospace, Defence, Medical and Analytical Instruments sectors. He began his career at Reliance Precision as an engineering apprentice and went on to graduate from Huddersfield University with a first-class BEng (hons) Engineering degree.

He has achieved accreditations as a Chartered Engineer with the Engineering Council and Chartered Manager with the Chartered Manager Institute. Throughout his career Richard has developed expertise in precision manufacturing and assembly techniques, with proven leadership experience in high reliability and complex engineering environments.

In 2025 Richard Joined Surgical Innovations as Production Director, where he oversees Production and Supply Chain function, ensuring operational excellence and continuous improvement across the business.